TAMPA, Fla.--(BUSINESS WIRE)--Sept. 14, 2006--Calgenex Corporation today announced that Joseph Jacobs, M.D., MBA, has joined the nutraceutical and personal care products company in the position of Consulting Medical Director.
Dr. Jacobs straddles the bridge between conventional and alternative therapies. He received his medical degree from Yale University, completed his residency at Dartmouth-Hitchcock Medical Center and Yale-New Haven Medical Center, and obtained his masters in business administration from the Wharton School of Business. He has authored and/or contributed to eight books including Cancer: Principles and Practice of Oncology, Medical Futility and the Complementary/Alternative Medicine: An Evidenced-Based Approach. Yet this doctor is just as familiar with traditional approaches to health care. Dr. Jacobs' mother was a full-blooded Caughnawaga Mohawk Indian and his father was part Cherokee. Growing up, he was exposed to numerous herbal medicines and healing ceremonies to cure sickness.
His intimate knowledge of both traditional and conventional medicine made Dr. Jacobs the perfect candidate for the position of director of the Office of Alternative Medicine at the National Institutes of Health, where he examined the scientific validity of various alternative treatments, such as acupuncture, chiropractic, herbal medicine, biofeedback and homeopathy.
"We are very pleased to have someone with Dr. Jacobs' experience in both alternative medicine and health care administration on our management team," commented Grant Carlson, president and CEO of Calgenex. The company manufactures and markets dietary supplement, topical over-the-counter (OTC) drugs, and personal care products specially formulated to combat the effects of soft tissue calcification and inflammation. "Dr. Jacobs began assisting the Company shortly after its founding in February 2006. Dr. Jacobs has always been a leader in healthcare innovation. As consulting medical director, he will help guide the clinical development of our products and communicate our message to both the medical community and the general public."
Dr. Jacobs shared Carlson's enthusiasm. "There is strong evidence that soft tissue calcification, or plaque, is a widespread health phenomenon affecting the health and quality of life of millions of Americans," stated Dr. Jacobs. "I think the folks at Calgenex are onto something very exciting that may improve the lives of millions."
Founded in 2006, Calgenex Corporation manufactures and markets dietary supplements, topical OTC drugs and personal care products specially formulated to combat the effects of soft tissue calcification and inflammation. Calgenex is located at 9950 Princess Palm Ave., Suite 320 in Tampa, Florida. For more information about the company or its products, please visit http://www.calgenex.com, phone 813-623-5268, or email email@example.com.